How to reframe the VA “Value” Proposition to ensure success in 2022
On Demand
In this webinar, Amplity’s VA practice lead and former VA VISN Pharmacy Executive, Jannet Carmichael, PharmD, reviews strategies to achieve meaningful awareness and adoption in today’s complex VA landscape.
Highlights of this session include how to successfully navigate new access limitations and reframe your organization’s understanding of current VA market dynamics.
Viewers will leave with a deep understanding of the VA’s current formulary process, national vs. regional engagement and how to use data to construct a tailored “Value” approach in this market.
You’ll learn about:
- Barriers – coverage and operational barriers to access
- Data – available data sources and how to use them
- Strategy – designing a VA-specific “Value” proposition and budget impact model
About our Presenter:
Jannet M. Carmichael, BS, Pharm.D., BCPS, FCCP, FAPhA
Is the Head of Amplity’s VA consulting group, providing launch and growth strategies to biopharma and medical device manufactures. Dr. Carmichael leads a team of VA Account Executives who coordinate and facilitate expedited access to VA decision makers in a shared-services capacity. Prior to her leadership role at Amplity, Jann was the VISN 21 Pharmacy Executive for the Veterans Health Administration where she cared for 650,000 veterans in Nevada, Northern California and Hawaii. Dr. Carmichael was the Director of the Clinical Data Warehouse in VISN 21. She coordinated pharmacy operations, Health Analytics, Pharmacoeconomics, Academic Detailing and Pharmacoepidemiology quality, safety and value programs using the Clinical Data Warehouse and health analytics for Veteran Integrated Service Network (VISN 21). Prior to this she was Clinical Pharmacy Coordinator at the VA Sierra Nevada Health Care System in Reno, Nevada and Associate Professor of Medicine at the University of Nevada School of Medicine. Her clinical practice includes primary care, population management and outcomes studies, programs that received the ASHP’s Best Practices in Health-System Pharmacy Award in 2002 and the ASHP Foundation Medication Safety Award in 2012. Jann served as Pharmacy Residency Program Director for the ASHP PGY2 Pharmacy Outcomes and Healthcare Analytics program.
Dr. Carmichael is a Past-President of ASHP and a former member of the Nevada Board of Pharmacy, Past-President Nevada Pharmacists Association and Nevada Pharmacy Alliance. Jann is a recipient of the ASHP 2013 Harvey A.K. Whitney Lecture Award, was named Federal Pharmacist of the Year by APhA in 2012 and University of Iowa Distinguished Alumni in 2011. She is past-Chair of the Board of Pharmaceutical Specialties (BPS), the BCPS Pharmacotherapy Council and is an ACPE Practitioner Reviewer and member of the ACEP International Commission, and ASHP Residency surveyor. Jann served as a member of the NQF Medication Management Steering Committee and was a member of the CMS Medication Measures Technical Expert Panel. Jann has authored hundreds of professional papers, book chapters and research projects. She is a frequent speaker on progressive pharmacy practice.
